Dr. Donald C. Shields, MD, PhD

Dr. Shields practices at Carolina Orthopaedic and Neurosurgical Associates in Spartanburg, South Carolina.

Dr. Shields' NPI, 1962460907, was assigned on May 1, 2006. Dr. Shields graduated from Medical University of South Carolina College of Medicine in 2000. Dr. Shields holds Massachusetts license 227465.

Dr. Shields' primary practice is Carolina Orthopaedic and Neurosurgical Associates, at 1330 Boiling Springs Rd, Spartanburg, SC 29303 in Spartanburg County. The practice phone is (864) 582-6396.

Dr. Shields' primary practice is Carolina Orthopaedic and Neurosurgical Associates in Spartanburg, South Carolina. Dr. Shields is also affiliated with Spartanburg Medical Center. The medical group on file is Carolina Orthopaedic & Neurosurgical Associates. Dmand AI also links Dr. Shields to 4 more hospitals, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shields practices, 8 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Shields' primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dmand AI has Dr. Shields' licenses on file in 2 states: Massachusetts and Maryland.

CMS data shows 1,363 Medicare services from Dr. Shields across 20 procedure codes in 2024, for 421 Medicare patients. Medicare paid $64,327 for them.

CMS counts 421 Medicare patients who saw Dr. Shields in 2024. The largest group is 65 to 74, with 191 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shields' median patient age at 68, with 58% women.

In 2024, Dr. Shields wrote 514 Medicare Part D claims for 183 patients. 95% of them were for generic drugs. CMS names the drug for 416 of them, across 10 drugs with 11 or more claims each, at $4,694 in total drug cost. In 2023, CMS named 493 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Shields for performance year 2024, reported as part of a group. Dr. Shields accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 52 procedures of laminectomy or laminotomy (partial removal of spine bones) by Dr. Shields, more than 78% of the clinicians it reports for that procedure.

Dmand AI links 25 papers to Dr. Shields, published from 2013 to 2024. 2020 was the busiest year, with 4. The most frequent topics are Calpain, Substantia Nigra and Deep Brain Stimulation. Dr. Shields has published most often in Epilepsy Behav. Dr. Shields' most frequent co-authors are Mohamad Z. Koubeissi, MD, Gregory L. Barkley, MD and Gregory Kent Bergey, MD.

CMS Open Payments shows 41 general payments to Dr. Shields from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 67% of the total. Medtronic USA, Inc. paid the most, $1,446. It also lists 6 research payments totaling $5,363 from 2016 to 2017.

Dr. Shields graduated from Medical University of South Carolina College of Medicine in 2000.